معرفی
Prof. Norbert Stefan is a Full Professor at the University of Tübingen's Department of Internal Medicine IV, specializing in clinical and experimental diabetology. His work focuses on metabolic health in obesity, nonalcoholic fatty liver disease (NAFLD), and hepatokine research.
- Pioneered metabolic phenotyping studies in the Tübingen Lifestyle Intervention Program (TULIP)
- Conducted seminal NIH/NIDDK research on adiponectin's role in insulin resistance in Pima Indian populations
- Developed the concept of hepatokines in 2008 with his colleagues
His 2025 publications span GLP-1 receptor agonists' effects on liver fibrosis, SGLT2 inhibitors' impact on liver events, and precision medicine approaches for metabolic dysfunction-associated steatotic liver disease. Current research integrates urinary peptidomics, brain insulin action studies, and advanced visceral fat quantification techniques.
Scientific Awards
- Innovation Award of the German Society for University Medicine (2010)
- Heisenberg-Professorship for Clinical and Experimental Diabetology (2011)
- Editorial Board Member, The Lancet Diabetes & Endocrinology (2015)
- Senior Associate Editor, Diabetes (2021)
Stefan maintains collaborative networks with Harvard Medical School, Boston Children's Hospital, the NIH, and consortia like SOPHIA IMI EU Consortium and the German Center for Diabetes Research.
